FDA Inspection 1010014 — Krystyna Jedynasty, MD
The FDA completed an inspection of Krystyna Jedynasty, MD on April 4, 2017 in Warsaw. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 4, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Warsaw (Poland)
Additional Details
Clinical Investigator (CI)